Acacia pulls IPO as European biotechs caught in U.S. downdraft: Reuters
Acacia Pharma (IPO-ACAC.L), a specialist in finding new uses for existing medicines, said on Friday it had postponed plans to float in London due to adverse market conditions.
16 October 2015•2 mins read
